Results 111 to 120 of about 7,240 (137)

Pernicious Anemia Presenting as Pseudo-Thrombotic Microangiopathy: A Case Report. [PDF]

Cureus
Mudupula Vemula SS, Adhikari S, Motkur S, Alshaikhli A, Hrinczenko B.   +4 more
europepmc   +1 more source

Multiphasic Infarcts in a Young Brain Secondary to Thrombotic Thrombocytopenic Purpura: Looking Beyond the Usual Suspects. [PDF]

Ann Indian Acad Neurol
Thejas NJA, Chattopadhyay AP, Kenchiah R, Pendharkar H, Mahale RR, Mailankody P, Padmanabha H.   +6 more
europepmc   +1 more source

Prediction of Functional Outcomes at Discharge Using Plasma Concentration of von Willebrand Factor Antigen at Admission in Hospitalized Patients with COVID-19. [PDF]

Ann Vasc Dis
Oki M, Yamasawa D, Goto S, Yanagi H, Manabe S, Kobayashi T, Tsuda A, Sato S, Morita S, Nakagawa Y, Oguma T, Asano K, Yamamoto N, Ozawa H, Goto S.   +14 more
europepmc   +1 more source

Recombinant ADAMTS13: An Enzyme Replacement Therapy for the Management of Congenital Thrombotic Thrombocytopenic Purpura. [PDF]

J Adv Pract Oncol
Robichaux TP, Dane KE, Parish PC, Arnall JR, Moore DC.   +4 more
europepmc   +1 more source

A red blood cell-based antigen delivery system to facilitate T cell epitope presentation to promote peripheral tolerance to ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura. [PDF]

Res Pract Thromb Haemost
Dierickx M, Groten S, Miranda M, Langerhorst P, van der Zwaan C, Mul E, Hoogendijk AJ, Voorberg J.   +7 more
europepmc   +1 more source

Ethnicity affects relapse-free survival in immunemediated thrombotic thrombocytopenic purpura. [PDF]

Haematologica
Weisinger J, Blanchard F, Suzon B, Deligny C, Fadlallah J, Provôt F, Poullin P, Marie M, Ribes D, Choukroun G, Delmas Y, Azoulay E, Benhamou Y, Grall M, Halimi JM, Le Quintrec M, Servais A, Papo T, Lepart C, Cartery C, Chatelet V, Augusto JF, Ville S, Perez P, Lièvre L, Legendre M, Rumpler A, Hertig A, Rieu V, Jaccard A, Zunic P, Gilardin L, Martis N, Puig SR, Gupte R, Garcia MDMT, Dierickx M, Greco D, Albrecht T, Icleanu AA, Bouzid R, Joly B, Veyradier A, Picod A, Coppo P.   +44 more
europepmc   +1 more source

[Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wei QZ, Lu C, Jiang HW, Hu JB, Wu YH, Hu Y.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura

Journal of Clinical Medicine, 2023
Kazuya Sakai, Karen Vanhoorelbeke, Quintijn Bonnez   +2 more
exaly  

Mechanisms of ADAMTS13 regulation

Journal of Thrombosis and Haemostasis, 2022
Colin Kretz, Kanwal Singh, Veronica Deyoung   +2 more
exaly  

A multicenter laboratory assessment of a new automated chemiluminescent assay for ADAMTS13 activity

Journal of Thrombosis and Haemostasis, 2021
Nathan Klose, Robyn Coleman
exaly